Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

John Messenger

Concepts (546)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Percutaneous Coronary Intervention
82
2024
549
7.520
Why?
Coronary Angiography
43
2024
325
4.070
Why?
Myocardial Infarction
49
2023
1212
3.230
Why?
Registries
72
2024
2382
2.970
Why?
Transcatheter Aortic Valve Replacement
12
2025
153
2.590
Why?
Coronary Artery Disease
29
2024
751
2.530
Why?
Aortic Valve Stenosis
12
2024
254
2.200
Why?
Cardiac Catheterization
25
2024
569
2.010
Why?
Angioplasty, Balloon, Coronary
25
2014
156
1.980
Why?
Cardiology
12
2022
363
1.390
Why?
Radial Artery
17
2022
74
1.350
Why?
Hemorrhage
23
2024
824
1.290
Why?
Hospital Mortality
30
2024
1037
1.140
Why?
Drug-Eluting Stents
13
2019
88
1.130
Why?
Cardiovascular Diseases
13
2023
2218
1.090
Why?
Acute Coronary Syndrome
11
2024
299
1.060
Why?
Femoral Artery
14
2022
183
0.980
Why?
Ultrasonography, Interventional
7
2015
163
0.950
Why?
Platelet Aggregation Inhibitors
14
2019
499
0.910
Why?
Heart Valve Prosthesis
4
2021
127
0.910
Why?
Treatment Outcome
80
2025
11744
0.910
Why?
Aged
123
2025
26251
0.890
Why?
Contrast Media
9
2024
492
0.870
Why?
Ticlopidine
7
2016
52
0.860
Why?
United States
86
2024
16041
0.850
Why?
Pacemaker, Artificial
19
2018
127
0.810
Why?
Aortic Valve
9
2024
360
0.810
Why?
Coronary Stenosis
8
2014
40
0.780
Why?
Influenza Pandemic, 1918-1919
1
2023
1
0.780
Why?
Coronary Artery Bypass
11
2021
268
0.780
Why?
Postoperative Complications
14
2025
2962
0.760
Why?
Imaging, Three-Dimensional
13
2016
578
0.750
Why?
Catheterization, Peripheral
7
2022
113
0.740
Why?
Coronary Vessels
13
2019
245
0.720
Why?
Humans
209
2025
145625
0.700
Why?
Purinergic P2Y Receptor Antagonists
7
2019
71
0.700
Why?
Influenza A Virus, H1N1 Subtype
1
2023
161
0.680
Why?
Risk Factors
49
2024
10840
0.680
Why?
Shock, Cardiogenic
10
2023
65
0.670
Why?
Stents
15
2016
551
0.670
Why?
Electrocardiography
21
2020
666
0.640
Why?
Time Factors
38
2024
7079
0.630
Why?
Acute Kidney Injury
5
2024
861
0.630
Why?
Computer Simulation
7
2014
1014
0.610
Why?
Hospitals
10
2022
730
0.600
Why?
Middle Aged
100
2024
36359
0.590
Why?
Radiography, Interventional
8
2019
127
0.570
Why?
Male
137
2025
73014
0.570
Why?
Coronary Disease
10
2012
380
0.570
Why?
Risk Assessment
26
2024
3678
0.560
Why?
Female
136
2025
79080
0.560
Why?
Coronary Restenosis
3
2013
22
0.540
Why?
ST Elevation Myocardial Infarction
4
2023
63
0.520
Why?
Fractional Flow Reserve, Myocardial
2
2013
10
0.480
Why?
Echocardiography, Three-Dimensional
4
2019
71
0.470
Why?
Practice Patterns, Physicians'
10
2019
1370
0.470
Why?
Models, Cardiovascular
3
2013
194
0.470
Why?
Myocardial Ischemia
6
2013
286
0.470
Why?
Hospitals, High-Volume
6
2021
49
0.470
Why?
Cardiac Pacing, Artificial
13
2007
83
0.460
Why?
Graft Occlusion, Vascular
4
2019
39
0.460
Why?
Follow-Up Studies
29
2021
5397
0.450
Why?
Hospitals, Low-Volume
5
2021
25
0.440
Why?
Endovascular Procedures
4
2025
385
0.440
Why?
Aged, 80 and over
39
2025
8351
0.440
Why?
Radiographic Image Interpretation, Computer-Assisted
9
2019
121
0.430
Why?
Allografts
1
2015
148
0.430
Why?
Prasugrel Hydrochloride
5
2016
22
0.420
Why?
Fluoroscopy
7
2021
177
0.420
Why?
Medicare
12
2021
907
0.420
Why?
Survival Rate
12
2021
2078
0.420
Why?
Patient Readmission
7
2024
771
0.410
Why?
Intra-Aortic Balloon Pumping
4
2021
19
0.410
Why?
Vascular Diseases
2
2015
251
0.390
Why?
Computer-Assisted Instruction
1
2013
69
0.380
Why?
Heart Arrest
4
2021
410
0.370
Why?
Postoperative Hemorrhage
4
2016
105
0.370
Why?
Heart Valve Prosthesis Implantation
4
2024
196
0.370
Why?
Quality Indicators, Health Care
5
2021
340
0.370
Why?
Retrospective Studies
40
2025
17291
0.370
Why?
Coronary Thrombosis
2
2012
25
0.370
Why?
Time-to-Treatment
4
2024
257
0.360
Why?
Heart-Assist Devices
4
2023
570
0.360
Why?
Length of Stay
7
2024
1342
0.360
Why?
Heart Defects, Congenital
4
2021
920
0.340
Why?
Patient Discharge
6
2024
991
0.340
Why?
Decision Support Techniques
6
2024
473
0.340
Why?
Heart Failure
3
2023
2323
0.330
Why?
Out-of-Hospital Cardiac Arrest
2
2024
121
0.330
Why?
Teaching
1
2013
243
0.330
Why?
Pneumonia, Viral
3
2020
387
0.320
Why?
Coronavirus Infections
3
2020
379
0.320
Why?
Coronary Aneurysm
1
2010
17
0.310
Why?
Heart Block
8
2018
41
0.310
Why?
Embolic Protection Devices
2
2024
12
0.310
Why?
Echocardiography, Transesophageal
4
2021
132
0.310
Why?
Hemostatic Techniques
3
2020
50
0.300
Why?
Arrhythmias, Cardiac
7
2023
358
0.300
Why?
Practice Guidelines as Topic
6
2020
1581
0.300
Why?
Peptide Fragments
6
2020
693
0.290
Why?
Anticoagulants
6
2015
743
0.290
Why?
Image Enhancement
2
2010
198
0.290
Why?
Clinical Competence
7
2017
1261
0.290
Why?
Heart Transplantation
1
2015
679
0.280
Why?
Predictive Value of Tests
16
2020
2097
0.280
Why?
Databases, Factual
6
2024
1481
0.280
Why?
Radiation Dosage
7
2016
193
0.270
Why?
Education, Medical, Graduate
1
2013
566
0.270
Why?
Cardiology Service, Hospital
2
2020
29
0.270
Why?
Hirudins
6
2020
52
0.270
Why?
Veterans
2
2019
1647
0.260
Why?
Myocardial Revascularization
6
2016
85
0.260
Why?
Patient Simulation
1
2008
42
0.260
Why?
Angioplasty
2
2010
48
0.260
Why?
Prospective Studies
22
2024
8087
0.250
Why?
Incidence
12
2020
2910
0.240
Why?
Device Removal
3
2005
149
0.240
Why?
Delivery of Health Care, Integrated
2
2021
304
0.240
Why?
Defibrillators, Implantable
3
2022
393
0.230
Why?
Quality Improvement
5
2019
1325
0.230
Why?
Workload
2
2019
169
0.230
Why?
Societies, Medical
4
2020
901
0.230
Why?
Multicenter Studies as Topic
2
2024
413
0.230
Why?
Pandemics
4
2023
1700
0.230
Why?
Electrocardiography, Ambulatory
2
2019
64
0.230
Why?
Antithrombins
4
2020
70
0.220
Why?
Consensus
4
2020
465
0.220
Why?
Drug Substitution
2
2016
62
0.220
Why?
Advisory Committees
2
2020
228
0.220
Why?
Prognosis
8
2024
4331
0.220
Why?
Comorbidity
8
2019
1652
0.220
Why?
Radiographic Image Enhancement
3
2006
56
0.220
Why?
Propensity Score
7
2020
370
0.220
Why?
Randomized Controlled Trials as Topic
5
2024
1754
0.220
Why?
Odds Ratio
10
2017
1070
0.210
Why?
American Heart Association
3
2016
363
0.210
Why?
Heart Septum
2
2015
27
0.210
Why?
Peripheral Vascular Diseases
2
2019
102
0.210
Why?
Education, Medical
1
2008
273
0.210
Why?
Angiography
4
2021
206
0.200
Why?
Cardiologists
2
2021
45
0.200
Why?
Thrombolytic Therapy
3
2020
165
0.200
Why?
Learning Curve
2
2015
71
0.200
Why?
Comparative Effectiveness Research
6
2016
170
0.200
Why?
Vascular Fistula
1
2024
21
0.200
Why?
Heart Diseases
3
2019
341
0.200
Why?
Kidney Diseases
2
2023
427
0.200
Why?
Aspirin
3
2015
404
0.200
Why?
Algorithms
8
2020
1843
0.190
Why?
Hypothermia, Induced
1
2024
96
0.190
Why?
Certification
2
2015
117
0.190
Why?
Cardiomyopathy, Hypertrophic
2
2015
144
0.190
Why?
Healthcare Disparities
3
2020
728
0.190
Why?
Stroke
7
2024
1283
0.190
Why?
Aorta, Thoracic
1
2025
284
0.190
Why?
Betacoronavirus
3
2020
288
0.190
Why?
Myocardial Reperfusion
2
2013
57
0.190
Why?
Cineangiography
5
2009
9
0.190
Why?
Heart Injuries
1
2023
41
0.190
Why?
Internship and Residency
1
2013
1269
0.180
Why?
Research Design
3
2022
1139
0.180
Why?
Intraoperative Care
2
2013
63
0.180
Why?
Age Factors
9
2020
3321
0.180
Why?
Severity of Illness Index
12
2020
2910
0.180
Why?
Heart Ventricles
6
2018
762
0.170
Why?
Enoxaparin
2
2015
68
0.170
Why?
History, 20th Century
1
2023
330
0.170
Why?
Technology Transfer
1
2021
9
0.170
Why?
Multimodal Imaging
2
2019
138
0.170
Why?
Sex Factors
5
2014
2101
0.170
Why?
Forecasting
2
2022
386
0.170
Why?
Guideline Adherence
3
2015
585
0.170
Why?
Inpatients
2
2024
538
0.170
Why?
Reproducibility of Results
9
2021
3396
0.160
Why?
Physicians
3
2015
954
0.160
Why?
Tachycardia, Ventricular
2
2024
179
0.160
Why?
Retreatment
3
2019
79
0.160
Why?
Renal Insufficiency, Chronic
3
2019
639
0.160
Why?
Surgicenters
1
2020
5
0.160
Why?
Breast Neoplasms
1
2013
2411
0.160
Why?
Ischemia
3
2009
421
0.160
Why?
Longitudinal Studies
10
2019
3005
0.160
Why?
Saphenous Vein
3
2015
36
0.160
Why?
Septal Occluder Device
2
2018
37
0.160
Why?
Manuals as Topic
1
2020
16
0.160
Why?
Proportional Hazards Models
8
2016
1318
0.160
Why?
Assisted Circulation
2
2021
26
0.150
Why?
Ethanol
2
2015
629
0.150
Why?
Chi-Square Distribution
6
2017
511
0.150
Why?
Thrombosis
3
2016
397
0.150
Why?
Extracorporeal Membrane Oxygenation
2
2021
369
0.150
Why?
Absorbable Implants
1
2019
38
0.140
Why?
Popliteal Artery
2
2009
59
0.140
Why?
Echocardiography, Doppler, Color
1
2019
37
0.140
Why?
Logistic Models
8
2017
2112
0.140
Why?
Rural Health Services
1
2020
138
0.140
Why?
Angina Pectoris
1
2019
76
0.140
Why?
Electrodes, Implanted
5
1999
113
0.140
Why?
Atrioventricular Block
1
2019
44
0.140
Why?
Infection Control
1
2020
174
0.140
Why?
Medicaid
2
2013
472
0.140
Why?
Vascular System Injuries
1
2019
79
0.140
Why?
Models, Anatomic
2
2009
87
0.140
Why?
Health Care Costs
2
2019
418
0.130
Why?
Recombinant Proteins
8
2020
1361
0.130
Why?
Image Processing, Computer-Assisted
3
2015
774
0.130
Why?
Quality of Health Care
2
2016
692
0.130
Why?
Myocardium
1
2023
948
0.130
Why?
Creatinine
4
2024
511
0.130
Why?
Rotation
5
2011
122
0.130
Why?
Subacute Care
1
2018
84
0.130
Why?
Cohort Studies
11
2023
6045
0.130
Why?
Efficiency, Organizational
1
2018
142
0.130
Why?
Purinergic P1 Receptor Antagonists
1
2016
10
0.120
Why?
Tissue Scaffolds
1
2019
220
0.120
Why?
Vascular Surgical Procedures
3
2009
341
0.120
Why?
Atrial Fibrillation
3
2007
559
0.120
Why?
Leg
2
2009
243
0.120
Why?
Angioplasty, Balloon
2
2007
92
0.120
Why?
Equipment Design
7
2014
519
0.120
Why?
Aortography
1
2016
52
0.120
Why?
Multidetector Computed Tomography
1
2016
40
0.120
Why?
Long Term Adverse Effects
1
2015
13
0.110
Why?
Proton Pump Inhibitors
1
2016
101
0.110
Why?
Heart Valve Diseases
2
2015
150
0.110
Why?
Drug Therapy, Combination
2
2015
1034
0.110
Why?
Syncope
1
2016
48
0.110
Why?
Aortic Valve Insufficiency
1
2015
43
0.110
Why?
Blood Loss, Surgical
2
2013
116
0.110
Why?
Unnecessary Procedures
1
2015
54
0.110
Why?
Metals
1
2016
137
0.110
Why?
Anterior Wall Myocardial Infarction
1
2015
4
0.110
Why?
Education, Medical, Continuing
2
2013
130
0.110
Why?
Vascular Grafting
1
2015
14
0.110
Why?
Injections
3
2014
199
0.110
Why?
Punctures
3
2020
40
0.110
Why?
Elective Surgical Procedures
2
2013
203
0.110
Why?
Ablation Techniques
1
2015
36
0.110
Why?
Computed Tomography Angiography
1
2016
151
0.110
Why?
Platelet Activation
1
2015
99
0.110
Why?
Patient Reported Outcome Measures
1
2019
502
0.110
Why?
Delivery of Health Care
2
2023
942
0.100
Why?
Heart Septal Defects, Atrial
1
2015
58
0.100
Why?
Quality Assurance, Health Care
2
2020
339
0.100
Why?
Radiation Injuries
1
2015
149
0.100
Why?
Therapy, Computer-Assisted
1
2014
55
0.100
Why?
Creatine Kinase, MB Form
1
2013
6
0.100
Why?
Catheter Ablation
1
2018
355
0.100
Why?
Pharmacogenetics
1
2015
176
0.100
Why?
Thrombectomy
2
2012
79
0.100
Why?
Prosthesis Design
2
2013
357
0.100
Why?
Clinical Decision-Making
3
2024
364
0.100
Why?
Warfarin
1
2015
179
0.100
Why?
Academies and Institutes
1
2013
60
0.100
Why?
Radiation
1
2013
24
0.100
Why?
Withholding Treatment
1
2014
77
0.100
Why?
Blood Vessel Prosthesis
2
2006
133
0.100
Why?
Hemostasis, Surgical
1
2013
25
0.100
Why?
Renal Dialysis
3
2014
458
0.090
Why?
Cardiac Volume
2
2003
14
0.090
Why?
Heparin
2
2015
246
0.090
Why?
Patient Selection
5
2019
720
0.090
Why?
Non-alcoholic Fatty Liver Disease
1
2015
265
0.090
Why?
Coronary Occlusion
1
2012
20
0.090
Why?
Coronary Artery Bypass, Off-Pump
1
2012
16
0.090
Why?
Wound Closure Techniques
1
2012
13
0.090
Why?
Medical Audit
1
2012
77
0.090
Why?
Fibrinolytic Agents
2
2009
302
0.090
Why?
Medication Adherence
1
2016
535
0.090
Why?
Diagnosis, Differential
3
2020
1500
0.090
Why?
Adult
19
2015
40821
0.090
Why?
Aneurysm, False
1
2012
45
0.090
Why?
Embolism
1
2012
49
0.090
Why?
Angina, Unstable
1
2012
83
0.090
Why?
Blood Platelets
1
2015
380
0.090
Why?
Health Services Accessibility
1
2020
1101
0.090
Why?
Triiodobenzoic Acids
2
2011
6
0.090
Why?
Electrophysiologic Techniques, Cardiac
1
2012
82
0.090
Why?
Insurance Claim Review
1
2012
85
0.080
Why?
Tomography, Optical Coherence
1
2013
277
0.080
Why?
Quality of Life
5
2019
3187
0.080
Why?
Polyethylene Terephthalates
1
1991
21
0.080
Why?
Ambulatory Care
1
2016
627
0.080
Why?
Diagnostic Imaging
1
2013
340
0.080
Why?
Phantoms, Imaging
2
2002
159
0.080
Why?
United States Department of Veterans Affairs
2
2019
777
0.080
Why?
Ventricular Function, Left
1
2014
541
0.080
Why?
Manikins
1
2010
37
0.080
Why?
Movement
2
2009
290
0.080
Why?
Cardiovascular Agents
4
2016
165
0.080
Why?
Kaplan-Meier Estimate
4
2014
959
0.080
Why?
Sensitivity and Specificity
4
2019
1992
0.070
Why?
Observer Variation
3
2011
355
0.070
Why?
Glomerular Filtration Rate
3
2023
743
0.070
Why?
Multivariate Analysis
4
2014
1531
0.070
Why?
Prosthesis Failure
1
2010
125
0.070
Why?
Coronary Vessel Anomalies
1
2009
38
0.070
Why?
Recurrence
4
2016
1125
0.070
Why?
Equipment Failure
2
2005
111
0.070
Why?
Liver Transplantation
1
2015
699
0.070
Why?
Drug Administration Schedule
3
2019
782
0.070
Why?
Cause of Death
3
2020
455
0.070
Why?
Prevalence
5
2019
2852
0.070
Why?
Vascular Closure Devices
2
2020
6
0.070
Why?
Carotid Stenosis
1
2009
103
0.070
Why?
Preoperative Period
2
2021
150
0.070
Why?
Heart Atria
6
1990
139
0.070
Why?
Hyperbaric Oxygenation
2
1998
39
0.070
Why?
Aftercare
2
2022
221
0.070
Why?
Emergency Service, Hospital
1
2020
2357
0.070
Why?
Embolization, Therapeutic
1
2010
246
0.060
Why?
Cardiac Output, Low
1
2007
53
0.060
Why?
Magnetic Resonance Angiography
2
2009
249
0.060
Why?
Extremities
1
2007
142
0.060
Why?
Stroke Volume
5
2015
651
0.060
Why?
Tomography, X-Ray Computed
3
2014
2766
0.060
Why?
Tuberculosis, Spinal
1
2006
8
0.060
Why?
Tissue Plasminogen Activator
2
1998
244
0.060
Why?
Survival Analysis
4
2013
1372
0.060
Why?
Mortality
3
2016
375
0.060
Why?
Treatment Refusal
1
2006
98
0.060
Why?
Hemodynamics
3
2020
1114
0.060
Why?
Systole
2
1983
179
0.060
Why?
Biomarkers
4
2023
4329
0.060
Why?
Lower Extremity
1
2009
449
0.050
Why?
Clinical Trials, Phase II as Topic
1
2024
74
0.050
Why?
Vascular Patency
3
2012
115
0.050
Why?
Cross-Sectional Studies
3
2022
5875
0.050
Why?
Sirolimus
1
2006
282
0.050
Why?
Intraoperative Complications
2
2018
154
0.050
Why?
Prosthesis Implantation
1
2006
155
0.050
Why?
Equipment Safety
1
2004
38
0.050
Why?
Patient Safety
2
2020
351
0.050
Why?
Ventricular Fibrillation
1
2024
63
0.050
Why?
Intracranial Embolism
1
2024
34
0.050
Why?
Risk
3
2012
917
0.050
Why?
Protective Factors
1
2024
97
0.050
Why?
Electric Countershock
1
2005
126
0.050
Why?
Adenosine
2
2016
255
0.050
Why?
Diabetes Mellitus
1
2012
1101
0.050
Why?
Prosthesis-Related Infections
1
2005
99
0.050
Why?
Peptides
1
2009
991
0.050
Why?
United States Food and Drug Administration
2
2016
207
0.050
Why?
Reoperation
2
2021
633
0.050
Why?
Blood Vessel Prosthesis Implantation
2
2004
218
0.050
Why?
Catheters
1
2023
71
0.050
Why?
Troponin
1
2023
50
0.050
Why?
Patient Preference
2
2016
224
0.050
Why?
Disability Evaluation
1
2024
297
0.050
Why?
Pyridines
1
2006
606
0.040
Why?
Risk Adjustment
2
2013
83
0.040
Why?
Kidney
2
2023
1491
0.040
Why?
Physical Exertion
1
1982
204
0.040
Why?
Diagnosis-Related Groups
1
2021
32
0.040
Why?
Myocardial Contraction
1
1982
292
0.040
Why?
Endocardium
2
1990
31
0.040
Why?
Mass Screening
1
2009
1300
0.040
Why?
Patient Participation
1
2024
454
0.040
Why?
Costs and Cost Analysis
2
2019
216
0.040
Why?
Curriculum
1
2008
1074
0.040
Why?
Hospitals, Teaching
1
2021
119
0.040
Why?
Pressure
2
2012
221
0.040
Why?
Angiotensin Receptor Antagonists
1
2021
115
0.040
Why?
Florida
1
2020
117
0.040
Why?
Population Density
1
2020
90
0.040
Why?
Matched-Pair Analysis
1
2020
37
0.040
Why?
International Classification of Diseases
1
2021
142
0.040
Why?
Heart Rate
4
2011
844
0.040
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2021
228
0.040
Why?
Ventricular Dysfunction, Left
1
2003
391
0.040
Why?
Tachycardia, Supraventricular
2
1990
50
0.040
Why?
Device Approval
1
2019
19
0.040
Why?
Organizational Innovation
1
2020
123
0.040
Why?
Travel
1
2020
133
0.040
Why?
Combined Modality Therapy
3
2012
1269
0.040
Why?
Models, Statistical
2
2014
667
0.040
Why?
Anatomic Landmarks
1
2019
31
0.040
Why?
Hospitals, University
1
2019
176
0.040
Why?
Patient-Specific Modeling
1
2019
46
0.040
Why?
Hospitals, Urban
1
2019
140
0.030
Why?
Writing
1
2020
101
0.030
Why?
Colorado
3
2019
4588
0.030
Why?
Cost-Benefit Analysis
2
2012
632
0.030
Why?
Plasminogen Activators
1
1997
7
0.030
Why?
Social Media
1
2020
158
0.030
Why?
Pulmonary Artery
1
2023
1116
0.030
Why?
Data Collection
1
2020
647
0.030
Why?
Exercise Test
3
2014
634
0.030
Why?
Residence Characteristics
1
2020
385
0.030
Why?
Adenosine Diphosphate
1
2016
75
0.030
Why?
Evidence-Based Medicine
1
2020
727
0.030
Why?
Disease Management
1
2020
649
0.030
Why?
Radiologic Health
1
2015
4
0.030
Why?
Automation
1
2016
104
0.030
Why?
Netherlands
1
2015
84
0.030
Why?
Technology Assessment, Biomedical
1
2015
44
0.030
Why?
Radiation Exposure
1
2016
62
0.030
Why?
Platelet Function Tests
1
2015
36
0.030
Why?
Drug Costs
1
2016
115
0.030
Why?
Gastrointestinal Hemorrhage
1
2016
133
0.030
Why?
Health Expenditures
1
2016
196
0.030
Why?
Single-Blind Method
2
2007
312
0.030
Why?
Early Termination of Clinical Trials
1
2014
18
0.030
Why?
Ventricular Outflow Obstruction
1
2015
38
0.030
Why?
Thrombelastography
1
2015
181
0.030
Why?
Radiology, Interventional
1
1994
49
0.030
Why?
Echocardiography, Stress
1
2014
29
0.030
Why?
Angina, Stable
1
2014
18
0.030
Why?
Hospital Costs
1
2015
127
0.030
Why?
Patient Admission
1
2016
216
0.030
Why?
Clinical Protocols
1
2015
279
0.030
Why?
Myocardial Perfusion Imaging
1
2014
50
0.020
Why?
Virginia
1
2013
57
0.020
Why?
Atrial Function
2
1990
10
0.020
Why?
Evaluation Studies as Topic
1
2013
160
0.020
Why?
Clinical Trials as Topic
1
2019
1062
0.020
Why?
Solvents
1
2014
112
0.020
Why?
Asymptomatic Diseases
1
2014
102
0.020
Why?
Professional Competence
1
2014
90
0.020
Why?
Blood Pressure
3
2011
1761
0.020
Why?
Echocardiography
2
2014
645
0.020
Why?
Foundations
1
2013
27
0.020
Why?
Cladribine
1
1993
1
0.020
Why?
Sinoatrial Node
2
1990
27
0.020
Why?
Administration, Oral
1
2015
867
0.020
Why?
Canada
1
2014
430
0.020
Why?
Research Report
1
2013
89
0.020
Why?
Telemetry
2
1989
40
0.020
Why?
Image Interpretation, Computer-Assisted
1
2015
295
0.020
Why?
Observation
1
2012
51
0.020
Why?
Linear Models
1
2014
847
0.020
Why?
Confidence Intervals
1
2012
328
0.020
Why?
Statistics as Topic
1
2012
277
0.020
Why?
Lymphoma, Non-Hodgkin
1
1993
124
0.020
Why?
Dose-Response Relationship, Drug
1
2015
2018
0.020
Why?
Posture
2
2009
180
0.020
Why?
Pectoralis Muscles
1
1991
18
0.020
Why?
Esthetics
1
1991
49
0.020
Why?
Psychomotor Agitation
1
1991
43
0.020
Why?
Software
1
2016
673
0.020
Why?
Age Distribution
1
2011
395
0.020
Why?
Consumer Behavior
1
1991
68
0.020
Why?
Sex Distribution
1
2011
379
0.020
Why?
Leukemia
1
1993
246
0.020
Why?
Health Care Surveys
1
2012
538
0.020
Why?
Automation, Laboratory
1
2010
8
0.020
Why?
X-Rays
1
2010
27
0.020
Why?
Tachycardia, Paroxysmal
1
1989
8
0.020
Why?
Torsion, Mechanical
1
2009
5
0.020
Why?
Adrenergic beta-Antagonists
1
2011
252
0.020
Why?
Suture Techniques
1
1991
137
0.020
Why?
Contraindications
1
2009
88
0.020
Why?
Hospitals, Veterans
1
2011
256
0.020
Why?
Graft Survival
1
2012
508
0.020
Why?
Multiple Myeloma
1
1993
310
0.020
Why?
Drug Prescriptions
1
2011
290
0.020
Why?
Medication Errors
1
2009
86
0.020
Why?
Feasibility Studies
2
2007
1125
0.020
Why?
Drug Utilization
1
2009
170
0.020
Why?
Calibration
1
2009
154
0.020
Why?
Diagnostic Errors
1
2010
178
0.020
Why?
Europe
1
2009
420
0.020
Why?
Magnetic Resonance Imaging
2
2014
3917
0.020
Why?
Infant, Newborn
1
2019
6449
0.020
Why?
Double-Blind Method
2
2003
2064
0.020
Why?
Ultrasonography, Doppler, Duplex
1
2007
39
0.020
Why?
Regression Analysis
1
2009
994
0.020
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2011
448
0.020
Why?
Veins
1
2007
68
0.020
Why?
Pain Measurement
1
2009
567
0.020
Why?
Life Tables
1
2006
21
0.020
Why?
Wound Healing
1
2009
348
0.010
Why?
Biomechanical Phenomena
1
2009
868
0.010
Why?
Coronary Circulation
1
1986
134
0.010
Why?
Drug Implants
1
2006
83
0.010
Why?
Program Evaluation
1
2010
945
0.010
Why?
Pattern Recognition, Automated
1
2006
74
0.010
Why?
Biopsy, Needle
1
2006
182
0.010
Why?
Regional Blood Flow
1
2007
507
0.010
Why?
Artifacts
1
2006
142
0.010
Why?
Aorta
1
2007
440
0.010
Why?
Probability
1
2005
308
0.010
Why?
Acute Disease
1
2007
1033
0.010
Why?
Streptokinase
2
1998
9
0.010
Why?
Diabetes Insipidus
1
1983
6
0.010
Why?
Whole-Body Irradiation
1
2004
73
0.010
Why?
Sputum
1
2006
302
0.010
Why?
Hospitalization
2
2006
2468
0.010
Why?
Antitubercular Agents
1
2006
211
0.010
Why?
Pain
1
2009
787
0.010
Why?
Sound
1
1983
49
0.010
Why?
Heart Function Tests
1
2003
59
0.010
Why?
Technology
1
1983
100
0.010
Why?
Critical Illness
1
2009
905
0.010
Why?
Echocardiography, Doppler
1
2003
117
0.010
Why?
Aging
1
2012
1983
0.010
Why?
Patient Education as Topic
1
2006
769
0.010
Why?
Artificial Intelligence
1
2006
385
0.010
Why?
Exercise Tolerance
1
2002
288
0.010
Why?
Stress, Mechanical
1
2002
493
0.010
Why?
Ultrasonography
1
2001
788
0.010
Why?
Exercise
1
1989
2206
0.010
Why?
Creatine Kinase
1
1997
70
0.010
Why?
Chronic Disease
1
2003
1824
0.010
Why?
Safety
1
1998
346
0.010
Why?
Subclavian Vein
1
1994
15
0.010
Why?
Traction
1
1994
19
0.010
Why?
Femoral Vein
1
1994
36
0.010
Why?
Staphylococcus epidermidis
1
1994
79
0.010
Why?
Steroids
1
1994
160
0.010
Why?
Cytarabine
1
1993
66
0.010
Why?
Mechlorethamine
1
1993
52
0.010
Why?
Drug Screening Assays, Antitumor
1
1993
194
0.010
Why?
Drug Resistance
1
1993
145
0.010
Why?
Vincristine
1
1993
148
0.010
Why?
Adolescent
3
1998
22451
0.010
Why?
Pilot Projects
1
1997
1878
0.010
Why?
Tumor Cells, Cultured
1
1993
878
0.010
Why?
Atrioventricular Node
1
1990
15
0.010
Why?
Body Constitution
1
1990
51
0.010
Why?
Doxorubicin
1
1993
414
0.000
Why?
Staphylococcal Infections
1
1994
396
0.000
Why?
Respiration
1
1990
207
0.000
Why?
Dizziness
1
1990
93
0.000
Why?
Syndrome
1
1990
377
0.000
Why?
Cardiac Complexes, Premature
1
1988
2
0.000
Why?
Refractory Period, Electrophysiological
1
1988
5
0.000
Why?
Dyspnea
1
1990
251
0.000
Why?
Fatigue
1
1990
362
0.000
Why?
Tromethamine
1
1986
2
0.000
Why?
Citrates
1
1986
41
0.000
Why?
Potassium Chloride
1
1986
39
0.000
Why?
Heart Arrest, Induced
1
1986
26
0.000
Why?
Protein Binding
1
1993
2239
0.000
Why?
Citric Acid
1
1986
33
0.000
Why?
Glutamates
1
1986
66
0.000
Why?
Aspartic Acid
1
1986
88
0.000
Why?
Phosphates
1
1986
175
0.000
Why?
Glutamic Acid
1
1986
255
0.000
Why?
Diuresis
1
1983
10
0.000
Why?
Arginine Vasopressin
1
1983
44
0.000
Why?
Vasopressins
1
1983
60
0.000
Why?
Anxiety
1
1990
1118
0.000
Why?
Heart
1
1986
624
0.000
Why?
Glucose
1
1986
1051
0.000
Why?
Surveys and Questionnaires
1
1990
6050
0.000
Why?
Messenger's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)